Clinical Trials Logo
  1. Home
  2. Intestinal Permeability
  3. NCT06262880

Dietary Supplementation on Gastrointestinal Barrier Function

Intestinal Permeability Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Effects of a Dietary Supplement Containing N-trans-Caffeoyltyramine (NCT) and N-trans-Feruloyltyramine (NFT) on Gastrointestinal Barrier Function

Clinical Trial Summary

The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI permeability. The primary hypothesis is that supplementation with plant derived phenolics will improve gut health compared to placebo.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06262880
Study type Interventional
Source Brightseed
Contact Doug Bolster, PhD
Phone (720)527-4131
Email doug.bolster@brightseedbio.com
Status Recruiting
Phase N/A
Start date February 6, 2024
Completion date February 6, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT03957239 - The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults N/A
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Recruiting NCT04109352 - Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
Completed NCT01424306 - Diet and Systemic Inflammation N/A
Completed NCT01241201 - Intestinal Barrier Function and Probiotics. N/A
Completed NCT01477034 - Vitamin D and Adipose Tissue Inflammation N/A
Recruiting NCT05257200 - Gut Permeability and Bariatric-metabolic Surgery
Completed NCT03027583 - The Effect of Probiotic Intervention on Intestinal Permeability N/A
Completed NCT03704727 - The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy N/A
Completed NCT01049386 - Intestinal Permeability Phase 2
Recruiting NCT04979130 - Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) Phase 4
Completed NCT01756040 - Intestinal Permeability in Preterm Infants Phase 1
Active, not recruiting NCT04083950 - Induction of Gut Permeability by an Oral Vaccine Early Phase 1
Completed NCT03113240 - Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients Phase 3